⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
prnewswire.com
JNJ
Johnson & Johnson to Participate in the Bernstein 2 nd Annual Healthcare Forum
businesswire.com
JNJ
Data published in The New England Journal of Medicine demonstrate RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) is re-setting survival expectations in first-line EGFR-mutated lung cancer
prnewswire.com
JNJ
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer
prnewswire.com
JNJ
Veterinary Implants Devices Market worth $0.98 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MRK
ELAN
JNJ
ZTS
HBIO
Melissa Etheridge to Accept 2026 Hope Award for Mental Health Advocacy at 20th Annual HOPE Luncheon Seminar
prnewswire.com
JNJ
Industry Report Shows 64% of Life Sciences Leaders Taking Action to Establish AI Governance
prnewswire.com
MRNA
PFE
JNJ
LUNGevity Foundation Launches Every Breath Forward℠ to Advance Progress and Improve Lives Nationwide
prnewswire.com
BIIB
AZN
JNJ
AMGN
LLY
MRK
REGN
The Galien Foundation Announces 2026 Prix Galien USA, International Prix Galien and Prix Galien Patient First Award Recipients
prnewswire.com
DNLI
GH
PT
CRC
REGN
SNY
VRTX
IMCR
BMY
LAB
JNJ
AZN
LUNGevity Foundation Unites Communities to Advance Progress During 2026 Lung Cancer Awareness Month
prnewswire.com
AZN
JNJ
AMGN
LLY
MRK
REGN